Grants Awarded



January 2017

GHRI recently received word of 19 new awards.

A Pilot Study of the Social Determinants of Healthcare for Substance Use Disorders

A one-year, $70,000 grant from Group Health Research Institute Development Fund. Major goals: To describe racial/ethnic, gender, and economic differences in the receipt of services for substance use disorders and demonstrate the feasibility of using Group Health medical charts to identify differences between these groups in how clinicians establish a diagnosis of substance use disorder. The principal investigator is Joseph E. Glass.

 

BP-CHECK Automated Office Blood Pressure (BP) Measurements

A nine-month, $30,235 grant from Group Health Research Institute Development Fund. Major goals: To add a fourth method of diagnosing hypertension, automated office blood pressure monitoring, to an existing study comparing multiple methods of diagnosing hypertension. The principal investigator is Beverly B. Green.

 

Building a Cost Effectiveness Analysis and Modeling Resource for Group Health Research Institute (GHRI)

A one-year, $50,000 grant from Group Health Research Institute Development Fund. Major goals: To develop a resource that would strength analytic and methodological capacity in cost-effectiveness analysis. The principal investigator is Kai Yeung.

 

Cancer Survivor Survey on Electronic Cigarettes and Symptom Burden

A six-month, $35,846 grant from Group Health Research Institute Development Fund. Major goals: To describe e-cigarette use and beliefs among lung and head and neck cancer survivors and estimate the prevalence of general and disease-specific symptoms in lung and head and neck cancer survivors. The principal investigator is Jessica Chubak.

 

Cannabis Use During Pregnancy:  Pilot Quantitative and Qualitative Data Needed to Obtain National Institute on Drug Abuse (NIDA) Funding

A one-year, $69,518 grant from Group Health Research Institute Development Fund. Major goals: To conduct preliminary quantitative and qualitative pilot work to describe the prevalence of cannabis use and the pregnancy outcomes, as well as possible reasons for cannabis use, among pregnant women attending Group Health in preparation for a future National Institute on Drug Abuse (NIDA) funded grant. The principal investigator is Gwen Lapham.

 

Center for Care Innovations - Safety Net Analytics Program

A one-year, $74,600 grant from Cedars-Sinai. Major goals: To evaluate the effectiveness of CCI's Safety Net Analytics Program to elevate successes and identify areas for improvement and spread. The Group Health Research Institute lead investigator is Maggie Jones.

 

Clare Fertility 2017

A one-year, $67,377 grant from Group Health Research Institute Development Fund. Major goals: To understand the lived experiences of adolescent and young adult (AYA) patients with advanced cancer who are making decisions about fertility preservation and family planning, and to use this understanding to make recommendations to care professionals who are advising AYA patients as they make choices about treatment. The principal investigator is Marlaine Gray.

 

Clare Opioids

A one-year, $30,375 grant from Group Health Research Institute Development Fund. Major goals: To understand the use of opioids in national claims based data for adolescent and young adult (AYA) patients. The principal investigator is Karen Wernli.

 

Developing Expertise in the Processing and Analysis of Accelerometer Data

A one-year, $40,000 grant from Group Health Research Institute Development Fund. Major goals: To develop biostatistical expertise at Group Health Research Institute (GHRI) for the analysis of accelerometer data. The newly developed expertise we be applied to advance two currently funded GHRI projects led by Dr. Rosenberg (ACT and ISTAND), and will provide the biostatistical knowledge base that will enable these data to be used successfully in future grant applications for ACT specifically and for the broader research institute. The principal investigator is Dori E. Rosenberg.

 

Development and Validation of a Tool for Automated Monitoring of Medication Allergies and Side Effects (AMMASE)

A six-month, $37,256 grant from Group Health Research Institute Development Fund. Major goals: To develop a natural language processing (NLP) system to automate the capture of medication side effect (MSE) descriptions appearing in electronic clinical text. This NLP system will be used to investigate the impact of MSEs on treatment adherence and outcomes for Group Health patients receiving antidepressants and antipsychotic medications.  The project will also support preparation of an external grant proposal. The principal investigator is David S. Carrell.

 

Group Health Cancer Research Program Research Specialist Award

A five-year, $948,128 grant from National Cancer Institute. Major goals: To support Erin Bowles as a scientist in various GHRI cancer research programs. The principal investigator is Erin J. Bowles.

 

Opening the Notes of Specialty Electronic Consultations to Patients

A one-year, $69,918 grant from Group Health Research Institute Development Fund. Major goals: To describe the initial experiences of patients, primary care providers, and specialty consultants with sharing electronic consultations with patients online and describe the initial adoption and use of shared electronic consultation with patients on line. The principal investigator is James D. Ralston.

 

Patient Perspectives on Routine Suicidality Screening: A Qualitative Evaluation

A one-year, $40,001 grant from Group Health Research Institute Development Fund. Major goals: To leverage behavioral health integration in the Group Health delivery system and examine the patient experience of being assessed for suicidality in the context of routine care. The principal investigator is Julie E. Richards.

 

Public Health Institute (PHI)-National Leadership Academy for the Public’s Health (NLAPH) Cohort 6 (C6) Appalachia

A ten-month, $5,000 grant from Centers for Disease Control and Prevention. Major goals: To evaluate the effectiveness of this leadership development program and provide information to Public Health Institute to inform course corrections. The Group Health Research Institute lead investigator is Maggie Jones.

 

Public Health Institute (PHI)-National Leadership Academy for the Public’s Health (NLAPH) Cohort 6 (C6) Competitive

A ten-month, $5,000 grant from Centers for Disease Control and Prevention. Major goals: To evaluate the effectiveness of this leadership development program and provide information to Public Health Institute to inform course corrections. The Group Health Research Institute lead investigator is Maggie Jones.

 

Public Health Institute (PHI)-National Leadership Academy for the Public’s Health (NLAPH) Cohort 6 (C6) US Virgin Islands (USVI)

A ten-month, $5,500 grant from Centers for Disease Control and Prevention. Major goals: To evaluate the effectiveness of this leadership development program and provide information to Public Health Institute to inform course corrections. The Group Health Research Institute lead investigator is Maggie Jones.

 

Public Health Institute (PHI)-National Leadership Academy for the Public’s Health (NLAPH) Cohort 6 (C6) Zika

A ten-month, $10,000 grant from Centers for Disease Control and Prevention. Major goals: To evaluate the effectiveness of this leadership development program and provide information to Public Health Institute to inform course corrections. The Group Health Research Institute lead investigator is Maggie Jones.

 

Physician Coaching: Value-Based Referrals

A one-year, $70,088 grant from Group Health Research Institute Development Fund. Major goals: To learn the effects of a physician coaching program on referral rates and patient experience. At the end of this study, we will have preliminary data for a future grant submission. We will also have a curriculum that could be implemented in medical training programs that could be evaluated. The principal investigator is Evette J. Ludman